In a patient with microcytic anemia, normal iron studies, markedly low haptoglobin, recent 16‑lb weight loss, and a peripheral smear showing few giant (macro‑oval) cells, many polychromatic (reticulocyte) red cells, marked anisocytosis and poikilocytosis, what is the most appropriate next diagnostic step?

Bone Marrow Examination with Aspirate and Biopsy

In this patient with microcytic anemia, normal iron studies, markedly low haptoglobin, significant weight loss, and a peripheral smear showing macro-oval cells, polychromatic cells (reticulocytes), and marked anisocytosis/poikilocytosis, the most appropriate next step is bone marrow examination with aspirate and biopsy to evaluate for myelodysplastic syndrome (MDS).

Clinical Reasoning

This presentation is highly concerning for MDS with concurrent hemolysis based on several key features:

Contradictory Red Cell Indices

• Microcytic anemia with normal iron studies immediately excludes iron deficiency anemia 1
• Presence of giant (macro-oval) cells alongside microcytosis suggests a dual population of red cells, which can occur when microcytosis and macrocytosis coexist and neutralize each other in the MCV calculation 2
• The marked anisocytosis and poikilocytosis on peripheral smear are characteristic dysplastic features seen in MDS 3, 4

Evidence of Hemolysis with Inadequate Marrow Response

• Markedly low haptoglobin indicates intravascular hemolysis 5
• Polychromatic cells (reticulocytes) suggest the marrow is attempting to respond 5
• However, the presence of microcytic anemia despite hemolysis suggests ineffective erythropoiesis rather than appropriate compensation 2

Red Flags for MDS

• 16-pound weight loss raises concern for underlying malignancy 5
• Giant cells, anisocytosis, and poikilocytosis are specific dysplastic features listed in MDS diagnostic criteria 3, 4
• The combination of hemolysis with dysplastic features suggests MDS with hemolysis, which is explicitly recognized in diagnostic algorithms 2

Why Bone Marrow Examination is Mandatory

According to European LeukemiaNet guidelines, bone marrow aspirate and biopsy are mandatory for MDS diagnosis 3:

Bone Marrow Aspirate Will Assess:

• Dysplasia in multiple cell lineages (>10% of cells in each lineage) 3
• Blast percentage for classification 3, 4
• Ring sideroblasts through iron staining (Perls stain), which are critical for subtyping MDS 3, 4
• Megaloblastoid changes that could indicate concurrent vitamin B12/folate deficiency 3

Bone Marrow Biopsy Will Evaluate:

• Cellularity (MDS typically shows hypercellularity) 3, 4
• Fibrosis which provides prognostic information 3, 4
• Megakaryocytic dysplasia which is better assessed on biopsy than aspirate 3

Cytogenetic Analysis is Mandatory:

• Chromosomal abnormalities are present in >80% of MDS cases 4
• Specific abnormalities like del(5q), -7/del(7q) provide both diagnostic confirmation and prognostic information 3

Important Caveats

Do Not Delay for Additional Blood Tests

While vitamin B12 and folate levels should be checked 5, 2, the constellation of findings here—particularly the combination of microcytosis with macro-oval cells, dysplastic features, hemolysis, and weight loss—mandates bone marrow examination regardless of vitamin levels 3.

Pseudo-TMA Consideration

The combination of hemolysis (low haptoglobin) with anisocytosis/poikilocytosis could suggest thrombotic microangiopathy 6. However, the presence of macro-oval cells and microcytic baseline makes vitamin B12 deficiency with pseudo-TMA less likely as the sole diagnosis 6, 7. MDS with hemolysis is the more concerning diagnosis that must be ruled out first 2.

Combined Deficiencies

MDS can coexist with nutritional deficiencies 2. The bone marrow examination will help distinguish:

• Pure MDS with dysplastic features
• MDS with concurrent B12/folate deficiency (megaloblastoid changes plus dysplasia)
• Combined deficiency states that may mask underlying clonal disorders 8

Diagnostic Algorithm Summary

1. Proceed directly to bone marrow examination with aspirate, biopsy, cytogenetics, and flow cytometry 3, 4
2. Simultaneously check vitamin B12, folate, LDH, and indirect bilirubin to quantify hemolysis 5, 2
3. Request Perls stain on bone marrow to identify ring sideroblasts 3, 4
4. Ensure cytogenetic analysis is performed as it is mandatory for MDS diagnosis and prognostication 3, 4

The weight loss, dysplastic peripheral smear features, and paradoxical combination of microcytosis with macro-oval cells in the setting of hemolysis make MDS the diagnosis that cannot be missed and requires immediate bone marrow evaluation 3, 4.